论文部分内容阅读
目的探讨立止血、甘露醇联合应用控制超早期脑出血继续出血的临床疗效。方法将104例超早期脑出血病人随机分为对照组和治疗组,对照组按脑出血常规治疗,治疗组在常规治疗的基础上超早期立止血和推迟的甘露醇治疗,对两组病人发病24 h继续出血发生率和血肿大小及治疗21 d后临床疗效进行比较。结果脑出血病人早期继续出血发生率治疗组明显低于对照组,其中3 h内入院者两组比较差异有统计学意义,而3～6 h入院者两组比较差异无统计学意义;两组病人发病24 h血肿体积均增大,但对照组同治疗组相比增大更明显;治疗21 d后临床疗效治疗组明显好于对照组。结论立止血、甘露醇联合应用能有效控制超早期脑出血继续出血,改善预后。
Objective To investigate the clinical efficacy of combination of hemostatic and mannitol to control hemorrhage after early cerebral hemorrhage. Methods One hundred and four patients with early-stage intracerebral hemorrhage were randomly divided into control group and treatment group. The control group was treated with conventional cerebral hemorrhage. The treatment group was treated with early stopping bleeding and delayed mannitol treatment on the basis of routine treatment. 24 h continue bleeding and hematoma size and size of the treatment after 21 d compared the clinical efficacy. Results The incidence of early continuous hemorrhage in patients with ICH was significantly lower in the treatment group than in the control group, and there was significant difference between the two groups in the 3 h admission, but there was no significant difference between the 3 and 6 h admission groups in the two groups The volume of hematoma increased 24 hours after onset, but the control group increased more obviously than that of the control group. After 21 days of treatment, the clinical efficacy of the treatment group was significantly better than that of the control group. Conclusion Liming blood, mannitol combined with effective control of early cerebral hemorrhage can continue to hemorrhage and improve prognosis.